Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Routine lab indicators like C-reactive protein and erythrocyte sedimentation rate help predict coronary artery lesions in children with Kawasaki disease.
GLP-1 agents address eating disorders by targeting appetite and gut-brain signaling pathways that regulate food reward and intake.
Doctors predict post-stroke cognitive impairment risk using clinical prediction models that combine factors like age, sex, blood biomarkers, and brain imaging findings.
High homocysteine levels are linked to post-stroke cognitive impairment, while the role of uric acid is mixed; neither is proven to directly cause it.
Yes, complement pathways are involved in kidney transplant rejection, including antibody-mediated rejection, and may be targeted for therapy.
Erythropoiesis-stimulating agents (ESAs) reduce total heart failure hospitalizations and improve exercise tolerance in adults with chronic heart failure and anaemia, but do not…
Yes, Xarelto (rivaroxaban) is FDA-approved for treating deep vein thrombosis (DVT) and reducing the risk of recurrent DVT.
Yes, Xarelto (rivaroxaban) is FDA-approved to reduce stroke risk in nonvalvular atrial fibrillation and to treat deep vein thrombosis, making it effective for patients with both…
Coping experiences for CHF patients and caregivers center on differing views of illness, emotional exhaustion, strained relationships, and a need for support to find new meaning.
Yes, the apical sparing ratio (ASR) can help detect cardiac amyloidosis, but it is not perfect—it has moderate accuracy and should be used alongside other tests.
No, alternative loop diuretics (torsemide, azosemide, piretanide) do not reduce hospitalizations compared to furosemide in chronic heart failure, based on a systematic review of…
Cardiac MRI with contrast and bone scintigraphy are the best tests for distinguishing cardiac amyloidosis from other heart issues, with echocardiography as a useful first…
Yes, education can help lower your risk of DVT after orthopedic surgery. A meta-analysis found that patients who received education had about half the risk of developing DVT…
A 2024 trial found that adding Qishen Yiqi dropping pills to standard Western medicine improved clinical effectiveness and heart function in chronic heart failure patients.
Experts suggest clinical remission in severe asthma means no exacerbations, no oral corticosteroids, good symptom control, and stable or optimal lung function.
Yes, biologic therapy significantly improves asthma control for patients with severe asthma, reducing exacerbations and improving symptoms and lung function.
Yes, tezepelumab is approved for severe asthma regardless of inflammation type, including low type 2 inflammation, though benefit may be smaller in these patients.
Lung function goals for severe asthma focus on achieving optimal individual FEV1 and maintaining stability, rather than normal values, as part of clinical remission.
Switching asthma biologics often reduces severe asthma attacks, improves lung function, and lowers the need for oral steroids, though the specific benefit depends on a patient's…
Yes, new therapies like CAR T cells, bispecific antibodies, and targeted drugs show high response rates in follicular lymphoma patients who progress within 24 months.
Adding R-CVP after radiotherapy significantly improves progression-free survival in early-stage follicular lymphoma, but overall survival benefit is not yet proven.
Yes, Revlimid (lenalidomide) is FDA-approved for previously treated follicular lymphoma, specifically in combination with rituximab.
Fixed-duration subcutaneous mosunetuzumab shows a favorable safety profile with lower rates of severe immune-related adverse events compared to the intravenous version in…
Abexinostat shows a 69.5% objective response rate in relapsed follicular lymphoma, based on a phase 2 trial.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.